title: Evaluation of the antitumor activity of the interleukin-12/pulse interleukin-2 combination.
authors.affiliation: Biological Carcinogenesis and Development Program, SAIC Frederick, Maryland, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Wigginton
authors.forename: K L
authors.initials: KL
authors.lastname: Komschlies
authors.forename: J E
authors.initials: JE
authors.lastname: Green
authors.forename: G W
authors.initials: GW
authors.lastname: Cox
authors.forename: C L
authors.initials: CL
authors.lastname: Jorcyk
authors.forename: T C
authors.initials: TC
authors.lastname: Back
authors.forename: J L
authors.initials: JL
authors.lastname: Franco
authors.forename: M J
authors.initials: MJ
authors.lastname: Brunda
authors.forename: R H
authors.initials: RH
authors.lastname: Wiltrout
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols; D004334:Drug Administration Schedule; D007167:Immunotherapy; D018664:Interleukin-12 / Q000008:administration & dosage*; D007376:Interleukin-2 / Q000008:administration & dosage*; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000628:therapy*; D016019:Survival Analysis
chemical_list: D007376:Interleukin-2; D018664:Interleukin-12